NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or "NewAmsterdam” or the "Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback